Germany
Japan
United Kingdom
China
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadAnti-PDCD1 / PD-1 / CD279 Reference Antibody (nivolumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (camrelizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cemiplimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (tislelizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (dostarlimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (retifanlimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nofazinlimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cetrelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (budigalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- PDCD1 / PD-1 / CD279
Reactivities
- Cynomolgus
Clonalities
- Monoclonal
Recombinant
- Recombinant Antibodies
Assay Types
- Indirect